Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
LimmaTech Biotechnologies
Biotech
Big Pharma-backed GlycoEra raises $130M for protein degraders
The cash will primarily go toward initiating clinical trials for GE8820, a bispecific molecule designed to destroy IgG4 autoantibodies.
Darren Incorvaia
May 27, 2025 7:00am
Valneva pays LimmaTech $10M for clinical-stage Shigella vaccine
Aug 1, 2024 8:26am
Stanford president resigns—Chutes & Ladders
Jul 21, 2023 9:30am
LimmaTech regains shigella shot from GSK, new CEO from CureVac
Jul 20, 2023 10:31am
